Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 Jul 26;68(10):e29247. doi: 10.1002/pbc.29247

FIGURE 1.

FIGURE 1

Serum cytokine levels following CD22 chimeric antigen receptor (CAR) T-cell administration (day 0). (A) Clinical time course of three cases with important clinical changes indicated on appropriate days with arrows. (B) Serum cytokine levels for three patients displayed in relation to other patients with CRS in the CD22 CAR clinical trial cohort (red, shaded area representing 70% confidence interval); steroids = steroids initiated; anakinra = anakinra initiated. Serial cytokines were resulted using ELISA on 58 subjects